The authors of this study analyzed neurological events and quality-of-life in the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) trial. A total of 1746 patients with aortic stenosis and intermediate surgical risk were randomized to either TAVI or SAVR.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk Patients
November 7, 2018
October 25, 2018
Olaf Wendler of King's College Hospital in London, UK, presents a discussion on the 2017 ESC/EACTS guidelines for the management of valvular heart disease.
October 17, 2018
Find it here: the 32nd EACTS Annual Meeting in Milan, Italy
Predicting Quality of Life at 1 Year After Transcatheter Aortic Valve Replacement in a Real-World Population
October 14, 2018
Despite the benefit for most patients, some patients have poor outcome after transcatheter aortic valve implantation (TAVI). Currently it is hard to predict which patient is predisposed to poor outcome at one year. This paper investigates the performance of a previously developed prediction model of poor outcome after TAVI.
In Global News: Wearable Ultrasound Patch to Monitor Blood Pressure in Deep Arteries, GALILEO Trial Halted, and CABG With Radial Artery Grafts
October 12, 2018
Patient Care and General Interest A family in Atlanta, Georgia, USA, whose 13-month-old daughter was born with pulmonic stenosis, has adopted a dog with the same congenital heart defect.
In Global News: World Heart Day, Treating Rheumatic Heart Disease in Rwanda, and TAVR Versus SAVR at TCT
September 28, 2018
Patient Care and General Interest Saturday, September 29 is World Heart Day! This year’s theme is “My Heart, Your Heart.”
September 25, 2018
This multicenter study evaluated the efficacy of medical therapy plus transcatheter valve repair (MitraClip) to medical therapy alone for heart failure accompanied by secondary moderate to severe mitral regurgitation. The device group experienced significantly fewer hospitalizations and lower mortality at 24 months follow-up.
September 16, 2018
Results of a clinical trial using transcatheter aortic valve replacement provided a "strong signal" that it is safe for patients with low surgical risk, potentially helping to open the way for broader use of the minimally invasive procedure, also known as TAVR.
September 13, 2018
Torsten Doenst of the University Heart Center Thuringen in Germany presents a discussion on the importance of long-term durability when considering conventional versus transcatheter valves.
Transcatheter Aortic Valve Implantation in Mitral Position in a Patient With Severe Mitral Annular Calcification
September 4, 2018
The authors demonstrate a transcatheter aortic valve that was implanted in the mitral position in the setting of severe mitral annular calcification.